Right Not to Know Genetic Risk Information Under Danish Law

The “right not to know” genetic information is an important principle in Danish health law, bioethics, and data protection law. It means that a person may refuse to receive information about genetic diseases, predispositions, or future medical risks discovered through genetic testing. Danish law recognizes that genetic information is uniquely sensitive because it concerns not only the individual patient but also biological relatives and future generations.

The Danish approach combines:

1. Patient autonomy
2. Human dignity
3. Informed consent
4. Protection of private life
5. Limits on disclosure of hereditary risk

The right is primarily regulated through the Danish Health Act, executive regulations on informed consent, the Danish Data Protection framework, and ethical guidelines developed by Danish health authorities and the Danish Council of Ethics.

I. Legal Foundations of the Right Not to Know in Denmark

1. Danish Health Act (Sundhedsloven)

The most direct legal recognition appears in Danish rules concerning informed consent and patient information.

The executive order on information and consent expressly states:

• Patients may refuse information about:
  • their present health condition,
  • treatment options,
  • diseases that may develop later in life.

This includes genetic predispositions and predictive genetic findings.

The regulation therefore legally recognizes:

• a negative autonomy right,
• meaning a patient can choose ignorance over knowledge.

This is particularly significant in genetics because predictive testing may reveal:

• Huntington’s disease,
• hereditary cancers,
• Alzheimer’s predispositions,
• untreatable neurodegenerative conditions.

Under Danish law, doctors generally cannot force unwanted genetic knowledge onto a patient unless exceptional public health or safety concerns exist.

2. Human Dignity and Self-Determination

Danish bioethics strongly emphasizes:

• bodily integrity,
• informational self-determination,
• personal autonomy.

The Danish Council of Ethics repeatedly argued that genetic information belongs to the core of personal identity and must remain under individual control.

The philosophical basis is that:

• knowledge of future disease risk may psychologically burden individuals,
• alter family relations,
• affect reproductive choices,
• create anxiety or social discrimination.

Therefore, the state should not compel genetic awareness.

3. Connection with European Human Rights Law

Although Denmark’s domestic law is central, the right not to know is also linked with:

• Article 8 of the European Convention on Human Rights (private life),
• the Oviedo Convention on Human Rights and Biomedicine.

The Oviedo Convention states that individuals may choose not to be informed about genetic findings.

Danish courts and health authorities interpret domestic law consistently with these European bioethical principles.

II. Scope of the Right Not to Know

The Danish approach recognizes the right in several contexts:

III. Detailed Case Law and Major Danish Legal Controversies

Denmark has relatively few classical reported “court judgments” exclusively about the right not to know. Instead, the doctrine developed through:

• administrative practice,
• ethics committee decisions,
• ombudsman-style reasoning,
• health authority interpretations,
• scholarly legal analysis,
• insurance and employment disputes.

Below are the most important cases and controversies shaping Danish law.

Case 1: Predictive Huntington’s Disease Testing and Refusal of Knowledge

Facts

One of the earliest controversies in Danish clinical genetics involved individuals at risk for Huntington’s disease.

Huntington’s disease:

• is hereditary,
• incurable,
• late-onset,
• highly predictive genetically.

Doctors faced situations where:

• relatives wanted testing,
• some family members refused to know,
• other relatives sought disclosure.

Legal Issue

Could physicians reveal hereditary risk information to family members who expressly wished not to know?

Danish Position

Danish medical ethics established that:

• predictive testing must be voluntary,
• informed consent is essential,
• individuals may decline testing completely.

Clinicians developed a practice whereby:

• no testing occurred without explicit consent,
• relatives’ wishes not to know had to be respected.

Importance

This became foundational for Danish genetic ethics because it established:

• autonomy over medical paternalism,
• the legitimacy of deliberate ignorance,
• the idea that future risk information differs from ordinary diagnosis.

Legal Principle Established

A competent adult has the right:

• not to undergo predictive testing,
• not to receive unwanted hereditary risk information.

This principle later influenced Danish legislation and clinical guidelines.

Case 2: Insurance Industry and Genetic Information Disputes

Background

Danish insurers historically sought access to genetic risk information for:

• life insurance,
• disability insurance,
• health coverage.

This created concern about:

• genetic discrimination,
• coercive testing,
• indirect destruction of the right not to know.

If insurance required genetic disclosure, individuals could effectively be forced into learning unwanted information.

Legislative Response

Denmark enacted strong restrictions through the Danish Insurance Contracts Act.

The law prohibits insurers from:

• demanding genetic tests,
• using predictive genetic information,
• requiring family genetic histories in many contexts. 

Core Legal Conflict

The insurance industry argued:

• risk assessment requires health information,
• adverse selection would destabilize insurance markets.

Privacy advocates argued:

• forcing disclosure destroys autonomy,
• individuals should not be economically punished for refusing genetic knowledge.

Legal Outcome

Danish law sided strongly with autonomy and privacy.

The prohibition was later expanded to include:

• hereditary family medical history in some circumstances. 

Significance

This is one of Europe’s strongest legal protections against genetic discrimination.

It indirectly protects the right not to know because:

• people are not pressured into testing,
• refusal to know does not automatically exclude insurance access.

Case 3: Genetic Testing of Children for Adult-Onset Diseases

Facts

Danish hospitals increasingly faced requests from parents seeking genetic testing of children for:

• hereditary cancers,
• Huntington’s disease,
• neurological disorders appearing only in adulthood.

Legal Question

Can parents authorize predictive testing that removes a child’s future choice not to know?

Danish Ethical Position

Danish genetic practice generally refuses such testing unless:

• early treatment exists,
• childhood intervention benefits the child medically.

The dominant reasoning is:

• the child’s future autonomy must be preserved,
• adulthood should bring the personal choice whether to know.

This principle was heavily discussed in Danish scholarship and clinical ethics literature.

Importance

This case line transformed the right not to know into an intergenerational right.

The issue became:

• not only whether adults may refuse information,
• but whether children should inherit the future freedom to choose ignorance.

Legal Principle

Parents cannot automatically override a child’s future informational autonomy when no immediate therapeutic benefit exists.

Case 4: Secondary Findings in Whole Genome Sequencing

Background

With modern genome sequencing, Danish hospitals increasingly discover “secondary findings”:

• unrelated disease risks,
• unexpected mutations,
• predispositions not connected to the original medical investigation.

Example:

• a cancer test may reveal Alzheimer’s risk.

Legal Problem

Must doctors disclose incidental findings even if:

• the patient did not ask,
• the patient previously indicated a wish not to know?

Danish Debate

Danish legal scholars and clinicians became divided.

One side argued:

• doctors have a duty to warn,
• serious preventable risks should be disclosed.

The opposing view argued:

• disclosure violates autonomy,
• the patient’s refusal must prevail.

Practical Danish Solution

Current Danish practice generally emphasizes:

• extensive pre-test counseling,
• advance consent choices,
• allowing patients to decide categories of information they wish to receive.

Significance

This controversy modernized the right not to know in the genomic era.

The issue shifted from:

• “whether to test”
  to:
• “how much unintended information must be disclosed.”

Case 5: The National Genome Center and Consent Controversies

Facts

Denmark established the Danish National Genome Center to centralize genomic data for personalized medicine.

Large-scale genomic collection raised concerns regarding:

• state access,
• future secondary uses,
• research disclosure,
• re-identification,
• involuntary discovery of disease risk.

Legal Questions

Could genomic data later reveal:

• diseases the patient never wanted to know about?
• familial risks?
• reproductive implications?

Could broad consent undermine the right not to know?

Danish Regulatory Response

Regulations required:

• informed written consent,
• patient information concerning use of genetic data,
• restrictions on secondary use.

Patients over 15 must specifically receive information concerning genetic self-determination.

Importance

This controversy expanded the right not to know from:

• doctor-patient relations
  to:
• large-scale state genomic governance.

Case 6: Employment Genetic Screening Controversies

Background

Concerns arose that employers might:

• screen applicants genetically,
• predict future illness,
• exclude high-risk workers.

Danish Law

The Danish Act on the Use of Health Information in the Labour Market strictly limits employer access to genetic information.

Employers generally cannot:

• request genetic tests,
• use hereditary information in hiring decisions.

Connection to the Right Not to Know

Without these restrictions:

• employees could be indirectly forced into genetic awareness,
• refusal to test could harm employment opportunities.

Legal Significance

The law recognizes that:

• economic pressure can destroy genuine consent,
• autonomy requires protection against institutional coercion.

Case 7: Familial DNA Searching and Genetic Privacy

Facts

Denmark increasingly uses familial DNA matching in criminal investigations.

In one highly discussed investigation, police identified a suspect through partial familial DNA comparison in the national DNA database.

Legal Issue

Familial searching may expose:

• biological relationships,
• inherited characteristics,
• family identities,
  without consent.

Relevance to the Right Not to Know

Relatives may discover:

• unknown parentage,
• criminal family links,
• hereditary connections,
  through state genetic analysis.

Danish Debate

Critics argued:

• genetic data affects entire families,
• one individual’s DNA disclosure implicates relatives who never consented.

Importance

This controversy shows that modern genetics challenges the traditional individual model of consent.

The right not to know becomes difficult when another person’s DNA indirectly reveals your own information.

IV. Danish Approach to Minors

Danish law distinguishes:

However, genetics complicates this because:

• genetic information may affect adulthood,
• parents’ decisions may permanently eliminate future autonomy.

Danish scholars criticize insufficient protection for children’s future right not to know.

V. Relationship with GDPR and Data Protection

Genetic data under EU GDPR is classified as:

• highly sensitive personal data.

Denmark applies strong protections concerning:

• storage,
• access,
• processing,
• secondary use.

However, GDPR mainly protects:

• informational control,
  not specifically:
• psychological non-disclosure.

Thus Danish health law fills the gap through informed-consent doctrine.

VI. Criticisms of the Danish Model

Several criticisms exist.

1. Family Interests vs Individual Autonomy

Genetic information is shared biologically.

If one person refuses knowledge:

• relatives may lose medically valuable information.

Conflict arises between:

• privacy,
• family protection.

2. Incidental Findings Problem

Whole-genome sequencing generates enormous amounts of data.

Doctors may discover:

• preventable cancers,
• lethal diseases,
• reproductive risks.

Some argue nondisclosure may itself be unethical.

3. Children’s Rights

Critics argue Danish law inadequately protects:

• children’s future autonomy,
• meaningful participation in genetic decisions.

4. Public Health Tensions

Some hereditary conditions may affect:

• reproductive planning,
• population health,
• preventive medicine.

The right not to know can conflict with:

• preventive healthcare goals.

VII. Overall Legal Position in Denmark

The Danish legal system strongly protects the right not to know genetic information through:

• informed consent,
• privacy rights,
• insurance restrictions,
• employment protections,
• ethical clinical practice.

The Danish model is notable because it treats genetic information as:

• exceptionally sensitive,
• identity-related,
• familial,
• psychologically significant.

The central principle is:

A person should normally control whether genetic knowledge about their future health enters their life at all.

At the same time, advances in:

• genomic medicine,
• AI diagnostics,
• national genetic databases,
• familial DNA searching,
  continue to challenge the boundaries of this right.